6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Bipolar Disorder: Diagnosis and Management
Navigating the complexity of bipolar disorder: diagnosis and management requires a nuanced understanding of mood fluctuations, energy levels, and behavioral changes. Accurate differentiation between unipolar depression and bipolar depression remains a clinical challenge, making early diagnosis essential. Long-term management strategies focus on mood stabilizers, lifestyle regulation, psychotherapy, and patient education. Advances in neuroimaging and genetic studies are refining classification systems, leading to improved personalized care. Comorbid conditions like anxiety, substance use, or ADHD can complicate treatment, highlighting the need for integrated approaches. Digital mood tracking tools and psychoeducation platforms are increasingly used to empower patients. Collaborative care models ensure continuity and reduce relapse rates.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States